Zobrazeno 1 - 10
of 389
pro vyhledávání: '"Shimon, Slavin"'
Autor:
Shani Zilberman-Itskovich, Ramzia Abu-Hamad, Rina Zarura, Marina Sova, Yafit Hachmo, Moshe Stark, Sara Neuman, Shimon Slavin, Shai Efrati
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222354 (2019)
IntroductionThe primary rational for using mesenchymal stromal cells (MSCs) to rejuvenate damaged tissue is mostly based on their capacity to trans-differentiate and repair injured organs. However, previous studies have demonstrated that MSCs are ben
Externí odkaz:
https://doaj.org/article/4c83bc14fd934fa68b78c6eed1b8de20
Autor:
Shimon Slavin
Purpose Unfortunately, cure of multi-drug resistant (MDR) hematologic malignancies remains an unmet need. Donor lymphocyte infusion (DLI) following allogeneic stem cell transplantation (SCT) can sometimes eliminate multi-drug resistant leukemia but a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c926c4d44a7c14bc1962a8000b388792
https://doi.org/10.21203/rs.3.rs-2606832/v1
https://doi.org/10.21203/rs.3.rs-2606832/v1
Autor:
Takayasu Ohtake, Shuzo Kobayashi, Shimon Slavin, Yasuhiro Mochida, Kunihiro Ishioka, Hidekazu Moriya, Sumi Hidaka, Ryo Matsuura, Maki Sumida, Daisuke Katagiri, Eisei Noiri, Kayoko Okada, Hiroshi Mizuno, Rica Tanaka
Publikováno v:
Cell Transplantation, Vol 27 (2018)
Acute kidney injury (AKI) is a major clinical problem that still has no established treatment. We investigated the efficacy of cultured human peripheral blood mononuclear cells (PBMNCs) for AKI. Ischemia/reperfusion injury (IRI) was used to induce AK
Externí odkaz:
https://doaj.org/article/9bfca39060864fe38bda0304369edaf5
Autor:
Shimon Slavin
Donor lymphocyte infusion using IL-2 activated donor lymphocytes following allogeneic stem cell transplantation (SCT) can sometimes eliminate multi-drug resistant (MDR) cancer cells and result in a cure. We hypothesized that more effective and faster
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e73e0a905396dc357f17cf6514ea81c7
https://doi.org/10.21203/rs.3.rs-2220581/v1
https://doi.org/10.21203/rs.3.rs-2220581/v1
Autor:
Tibor Bakacs, Volker Sandig, Shimon Slavin, Serhat Gumrukcu, David Hardy, Wolfgang Renz, Imre Kovesdi
Publikováno v:
Infectious disorders drug targets.
Abstract: More than 200 viruses infect humans, but treatments are available for less than ten of them. To narrow the gap between ‘bugs and drugs,’ a paradigm shift is required. The “one drug, one bug” approach can be expanded to a “one drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c87b734c87548bd67906bb9b31d940
https://pubmed.ncbi.nlm.nih.gov/35440336
https://pubmed.ncbi.nlm.nih.gov/35440336
Currently, SARS-CoV-2 infection which is the causative agent for COVID-19 disease is a worldwide pandemic with more than 100 million global cases and more than 2.0 million deaths (as of January, 2021). While several vaccines for prevention of COVID-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c59a25b40a1274c95e6d2da4d73145b
https://doi.org/10.20944/preprints202002.0147.v4
https://doi.org/10.20944/preprints202002.0147.v4
Autor:
Hae Kyung Lee, Ariel Bier, Simona Cazacu, Susan Finniss, Cunli Xiang, Hodaya Twito, Laila M Poisson, Tom Mikkelsen, Shimon Slavin, Elad Jacoby, Michal Yalon, Amos Toren, Sandra A Rempel, Chaya Brodie
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e54652 (2013)
Glioblastomas (GBM), the most common and aggressive type of malignant glioma, are characterized by increased invasion into the surrounding brain tissues. Despite intensive therapeutic strategies, the median survival of GBM patients has remained disma
Externí odkaz:
https://doaj.org/article/5b4578dbd2514421a2e85381362b4f5c
Autor:
Daisuke Katagiri, Takayasu Ohtake, Ryo Matsuura, Yasuhiro Mochida, Kunihiro Ishioka, Rica Tanaka, Sumi Hidaka, Shimon Slavin, Eisei Noiri, Kayoko Okada, Maki Sumida, Hidekazu Moriya, Shuzo Kobayashi, Hiroshi Mizuno
Publikováno v:
Cell Transplantation, Vol 27 (2018)
Cell Transplantation
Cell Transplantation
Acute kidney injury (AKI) is a major clinical problem that still has no established treatment. We investigated the efficacy of cultured human peripheral blood mononuclear cells (PBMNCs) for AKI. Ischemia/reperfusion injury (IRI) was used to induce AK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64c523421e43492bcfcca7ac2bc6cdd
https://doi.org/10.1177/0963689717753186
https://doi.org/10.1177/0963689717753186
Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation.
Autor:
Menachem Bitan, Lola Weiss, Michael Zeira, Eyal Zcharia, Shimon Slavin, Arnon Nagler, Israel Vlodavsky
Publikováno v:
PLoS ONE, Vol 5, Iss 4, p e10135 (2010)
Heparanase, endoglycosidase that cleaves heparan sulfate side chains of heparan sulfate proteoglycans, plays important roles in cancer metastasis, angiogenesis and inflammation.Applying a mouse model of bone marrow transplantation and transgenic mice
Externí odkaz:
https://doaj.org/article/a662c68f2b634fd0ba958fe9b567ab48
Autor:
Orit Uziel, Einat Beery, Vladimir Dronichev, Katty Samocha, Sergei Gryaznov, Lola Weiss, Shimon Slavin, Michal Kushnir, Yardena Nordenberg, Claudette Rabinowitz, Baruch Rinkevich, Tania Zehavi, Meir Lahav
Publikováno v:
PLoS ONE, Vol 5, Iss 2, p e9132 (2010)
BACKGROUND: Telomere/telomerase system has been recently recognized as an attractive target for anticancer therapy. Telomerase inhibition results in tumor regression and increased sensitivity to various cytotoxic drugs. However, it has not been fully
Externí odkaz:
https://doaj.org/article/53ffb21a28e645e787473b7344525ce5